BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21380901)

  • 1. Synthesis of peptidomimics through sugar-based scaffolds.
    Le Merrer Y; Poitout L; Depezay JC
    Methods Mol Med; 1999; 23():227-57. PubMed ID: 21380901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
    Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
    Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methylation of peptides: a new perspective in medicinal chemistry.
    Chatterjee J; Gilon C; Hoffman A; Kessler H
    Acc Chem Res; 2008 Oct; 41(10):1331-42. PubMed ID: 18636716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Asymmetric Synthesis Protocol to Prepare Topographically Constrained β-Substituted Aromatic Amino Acids.
    Liao S; Hruby VJ
    Methods Mol Med; 1999; 23():175-87. PubMed ID: 21380898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of peptides and other drugs using lipoamino acids and sugars.
    Blanchfield JT; Toth I
    Methods Mol Biol; 2005; 298():45-61. PubMed ID: 16044539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity.
    Chorev M; Roubini E; Gilon C; Selinger Z
    Biopolymers; 1991 May; 31(6):725-33. PubMed ID: 1718472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data.
    Varin T; Schuffenhauer A; Ertl P; Renner S
    J Chem Inf Model; 2011 Jul; 51(7):1528-38. PubMed ID: 21615076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrates in peptide and protein design.
    Jensen KJ; Brask J
    Biopolymers; 2005; 80(6):747-61. PubMed ID: 15929028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and conformational analysis of eight-membered cyclic peptidomimetics prepared using ring closing metathesis.
    Creighton CJ; Leo GC; Du Y; Reitz AB
    Bioorg Med Chem; 2004 Aug; 12(16):4375-85. PubMed ID: 15265489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel chemical approach to drug delivery: lipidic amino acid conjugates.
    Toth I
    J Drug Target; 1994; 2(3):217-39. PubMed ID: 7812692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the conformational mimicry of the measles virus HNE loop: design, synthesis and biological evaluation of a cyclic bile acid-peptide conjugate.
    Bodé CA; Bechet T; Prodhomme E; Gheysen K; Gregoir P; Martins JC; Muller CP; Madder A
    Org Biomol Chem; 2009 Sep; 7(17):3391-9. PubMed ID: 19675892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of ferrocene-dipeptide bioorganometallic conjugates to induce chirality-organized structures.
    Moriuchi T; Hirao T
    Acc Chem Res; 2010 Jul; 43(7):1040-51. PubMed ID: 20377253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering cyclic peptide toxins.
    Clark RJ; Craik DJ
    Methods Enzymol; 2012; 503():57-74. PubMed ID: 22230565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of macrolide-saccharide hybrids by ring-closing metathesis of precursors derived from glycitols and benzoic acids.
    Matos MC; Murphy PV
    J Org Chem; 2007 Mar; 72(5):1803-6. PubMed ID: 17274658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    Parker KC; Bednarek MA; Coligan JE
    J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dde resin based strategy for inverse solid-phase synthesis of amino terminated peptides, peptide mimetics and protected peptide intermediates.
    Rai A; Gutheil WG
    J Pept Sci; 2005 Feb; 11(2):69-73. PubMed ID: 15635629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
    Boeglin D; Lubell WD
    J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.